Mrs. Fischer-Hansen joined the Board of Directors of Abacus Medicine in 2021.
Mrs. Fischer-Hansen is Executive Vice President at Falck and member of the Executive Management. She brings experience within commercial effectiveness, marketing, pharma economics and market access.
Prior to joining Falck in 2019, Michala Fischer-Hansen had a 19-year international career at Novo Nordisk, i.a. as VP and General Manager for Novo Nordisk operations in Australia and New Zealand., as Corporate Vice President HQ Marketing, and Senior Director at Novo Nordisk Inc. in the US.
Mrs. Fischer-Hansen has studied at the Copenhagen Business School, the Wharton School and Harvard Business School, and holds a master’s degree in international business.